Terms: = Bone cancer AND SETD2, ENSG00000181555, 29072 AND Prognosis
2 results:
1. Histone H3G34 Mutation in Brain and bone Tumors.
Qiu L; Han J
Adv Exp Med Biol; 2021; 1283():63-71. PubMed ID: 33155138
[TBL] [Abstract] [Full Text] [Related]
2. setd2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
